-+ 0.00%
-+ 0.00%
-+ 0.00%

ALECTOR ANNOUNCES COMPLETION OF ENROLLMENT IN THE PROGRESS-AD PHASE 2 CLINICAL TRIAL OF AL101/GSK4527226 IN INDIVIDUALS WITH EARLY ALZHEIMER’S DISEASE

Reuters·04/17/2025 12:00:03

Please log in to view news